Azolylthioacetamides as a potent scaffold for the development of metallo-beta-lactamase inhibitors
Azolylthioacetamides as a potent scaffold for the development of metallo-beta-lactamase inhibitors
复制标题
唑基硫代乙酰胺作为开发金属-β-内酰胺酶抑制剂的有效支架
DOI:
10.1016/j.bmcl.2017.10.038
复制
发表时间:
2017
影响因子:
2.7
通讯作者:
Yang Ke Wu
中科院分区:
文献类型:
--
作者:
Yang Xiang;Chang Ya Nan;Ge Ying;Kang Joon S;Zhang Yi Lin;Liu Xiao Long;Oelschlaeger Peter;Yang Ke Wu
In an effort to develop new inhibitors of metallo-β-lactamases (MβLs), twenty-eight azolylthioacetamides were synthesized and assayed against MβLs. The obtained benzimidazolyl and benzioxazolyl substituted1–19specifically inhibited the enzyme ImiS, and10was found to be the most potent inhibitor of ImiS with an IC50value of 15 nM. The nitrobenzimidazolyl substituted20–28specifically inhibited NDM-1, with27being the most potent inhibitor with an IC50value of 170 nM. Further studies with10,11, and27revealed a mixed inhibition mode with competitive and uncompetitive inhibition constants in a similar range as the IC50values. These inhibitors resulted in a 2–4-fold decrease in imipenem MIC values usingE. colicells producing ImiS or NDM-1. While the source of uncompetitive (possibly allosteric) inhibition remains unclear, docking studies indicate that10and11may interact orthosterically with Zn2 in the active site of CphA, while27could bridge the two Zn(II) ions in the active site of NDM-1viaits nitro group.